These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1179 related articles for article (PubMed ID: 33914047)
1. Association of 1-Year Blood Pressure Variability With Long-term Mortality Among Adults With Coronary Artery Disease: A Post Hoc Analysis of a Randomized Clinical Trial. Dasa O; Smith SM; Howard G; Cooper-DeHoff RM; Gong Y; Handberg E; Pepine CJ JAMA Netw Open; 2021 Apr; 4(4):e218418. PubMed ID: 33914047 [TBL] [Abstract][Full Text] [Related]
2. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. Pepine CJ; Handberg EM; Cooper-DeHoff RM; Marks RG; Kowey P; Messerli FH; Mancia G; Cangiano JL; Garcia-Barreto D; Keltai M; Erdine S; Bristol HA; Kolb HR; Bakris GL; Cohen JD; Parmley WW; JAMA; 2003 Dec; 290(21):2805-16. PubMed ID: 14657064 [TBL] [Abstract][Full Text] [Related]
3. Effects of verapamil SR and atenolol on 24-hour blood pressure and heart rate in hypertension patients with coronary artery disease: an international verapamil SR-trandolapril ambulatory monitoring substudy. Denardo SJ; Gong Y; Cooper-DeHoff RM; Farsang C; Keltai M; Szirmai L; Messerli FH; Bavry AA; Handberg EM; Mancia G; Pepine CJ PLoS One; 2015; 10(4):e0122726. PubMed ID: 25835002 [TBL] [Abstract][Full Text] [Related]
4. INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study. Cooper-DeHoff RM; Handberg EM; Mancia G; Zhou Q; Champion A; Legler UF; Pepine CJ Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1329-40. PubMed ID: 19900016 [TBL] [Abstract][Full Text] [Related]
5. Mortality implications of lower DBP with lower achieved systolic pressures in coronary artery disease: long-term mortality results from the INternational VErapamil-trandolapril STudy US cohort. Wokhlu A; Smith SM; Gong Y; Handberg EM; Elgendy IY; Bavry AA; Cooper-DeHoff RM; Pepine CJ J Hypertens; 2018 Feb; 36(2):419-427. PubMed ID: 28938338 [TBL] [Abstract][Full Text] [Related]
6. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST). Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ; Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902 [TBL] [Abstract][Full Text] [Related]
7. Dual therapy in hypertensive patients with coronary artery disease: the role of calcium channel blockers and beta-blockers. Bakris GL; Cooper-Dehoff RM; Zhou Q; Kupfer S; Champion A; Pepine CJ; Am J Cardiovasc Drugs; 2007; 7 Suppl 1():25-9. PubMed ID: 19845074 [TBL] [Abstract][Full Text] [Related]
8. Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. Bangalore S; Messerli FH; Franklin SS; Mancia G; Champion A; Pepine CJ Eur Heart J; 2009 Jun; 30(11):1395-401. PubMed ID: 19351690 [TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST): an Internet-based randomized trial in coronary artery disease patients with hypertension. Pepine CJ; Handberg-Thurmond E; Marks RG; Conlon M; Cooper-DeHoff R; Volkers P; Zellig P J Am Coll Cardiol; 1998 Nov; 32(5):1228-37. PubMed ID: 9809930 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST). Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ; Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338 [TBL] [Abstract][Full Text] [Related]
11. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. Cooper-DeHoff RM; Gong Y; Handberg EM; Bavry AA; Denardo SJ; Bakris GL; Pepine CJ JAMA; 2010 Jul; 304(1):61-8. PubMed ID: 20606150 [TBL] [Abstract][Full Text] [Related]
12. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Messerli FH; Mancia G; Conti CR; Hewkin AC; Kupfer S; Champion A; Kolloch R; Benetos A; Pepine CJ Ann Intern Med; 2006 Jun; 144(12):884-93. PubMed ID: 16785477 [TBL] [Abstract][Full Text] [Related]
13. Mortality implications of angina and blood pressure in hypertensive patients with coronary artery disease: New data from extended follow-up of the International Verapamil/Trandolapril Study (INVEST). Winchester DE; Cooper-Dehoff RM; Gong Y; Handberg EM; Pepine CJ; Clin Cardiol; 2013 Aug; 36(8):442-7. PubMed ID: 23720247 [TBL] [Abstract][Full Text] [Related]
14. Genetic Variants Associated With Uncontrolled Blood Pressure on Thiazide Diuretic/β-Blocker Combination Therapy in the PEAR (Pharmacogenomic Evaluation of Antihypertensive Responses) and INVEST (International Verapamil-SR Trandolapril Study) Trials. Magvanjav O; Gong Y; McDonough CW; Chapman AB; Turner ST; Gums JG; Bailey KR; Boerwinkle E; Beitelshees AL; Tanaka T; Kubo M; Pepine CJ; Cooper-DeHoff RM; Johnson JA J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097388 [TBL] [Abstract][Full Text] [Related]
15. Risk and Blood Pressure Control Rates Across the Spectrum of Coronary Artery Disease in Hypertensive Women: An Analysis from The INternational VErapamil SR-Trandolapril STudy (INVEST). Sava RI; Chen YE; Smith SM; Gong Y; Cooper-DeHoff RM; Keeley EC; Pepine CJ; Handberg EM J Womens Health (Larchmt); 2020 Feb; 29(2):158-166. PubMed ID: 31403360 [No Abstract] [Full Text] [Related]
16. Systolic blood pressure and subjective well-being in patients with coronary artery disease. Gong Y; Handberg EM; Gerhard T; Cooper-Dehoff RM; Ried LD; Johnson JA; Pepine CJ; Clin Cardiol; 2009 Nov; 32(11):627-32. PubMed ID: 19711440 [TBL] [Abstract][Full Text] [Related]